Teladoc Health Stock Forecast, Price & News

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TDOC shares have increased by 61.7% and is now trading at $222.23.
View which stocks have been most impacted by COVID-19.

28 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 11 hold ratings and 17 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Teladoc Health.

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Teladoc Health.

Teladoc Health will be holding an earnings conference call on Wednesday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Teladoc Health, Inc. (NYSE:TDOC) posted its earnings results on Wednesday, July, 29th. The health services provider reported ($0.34) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.23) by $0.11. The health services provider had revenue of $241.03 million for the quarter, compared to analyst estimates of $220.49 million. Teladoc Health had a negative return on equity of 9.54% and a negative net margin of 13.22%. The business's quarterly revenue was up 85.0% compared to the same quarter last year. During the same quarter last year, the business earned ($0.41) EPS.
View Teladoc Health's earnings history.

Teladoc Health updated its FY20 earnings guidance on Wednesday, July, 29th. The company provided earnings per share (EPS) guidance of ($1.45-1.36) for the period, compared to the Thomson Reuters consensus EPS estimate of ($0.97). The company issued revenue guidance of $980-995 million, compared to the consensus revenue estimate of $872.82 million.

28 equities research analysts have issued 1 year price objectives for Teladoc Health's stock. Their forecasts range from $80.00 to $282.00. On average, they anticipate Teladoc Health's share price to reach $214.57 in the next twelve months. This suggests that the stock has a possible downside of 3.4%.
View analysts' price targets for Teladoc Health.

Teladoc Health saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 15,830,000 shares, an increase of 14.8% from the August 31st total of 13,790,000 shares. Based on an average daily trading volume, of 3,710,000 shares, the days-to-cover ratio is presently 4.3 days.
View Teladoc Health's Short Interest.

Some companies that are related to Teladoc Health include Anthem (ANTM), GlaxoSmithKline plc (GSK.L) (GSK), Becton, Dickinson and (BDX), Regeneron Pharmaceuticals (REGN), Humana (HUM), Vertex Pharmaceuticals (VRTX), Boston Scientific (BSX), Takeda Pharmaceutical (TAK), Edwards Lifesciences (EW), Bayer (BAYRY), Lonza Group (LZAGY), Illumina (ILMN), HCA Healthcare (HCA), Bayer (BAYN) and Biogen (BIIB).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), Shopify (SHOP), Docusign (DOCU), salesforce.com (CRM), Paypal (PYPL) and Zoom Video Communications (ZM).

(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Teladoc Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (0.66%), Peregrine Capital Management LLC (0.20%), Envestnet Asset Management Inc. (0.16%), Nissay Asset Management Corp Japan ADV (0.13%), Scout Investments Inc. (0.11%) and Carnegie Capital Asset Management LLC (0.03%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, David William Sides, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete and William H Frist.
View institutional ownership trends for Teladoc Health.

TDOC stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Riverbridge Partners LLC, Spence Asset Management, Assenagon Asset Management S.A., Scout Investments Inc., Avitas Wealth Management LLC, Chicago Capital LLC, and Gradient Investments LLC. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, David William Sides, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Stephany Verstraete, and William H Frist.
View insider buying and selling activity for Teladoc Health.

TDOC stock was acquired by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Nissay Asset Management Corp Japan ADV, Hall Laurie J Trustee, Avantax Advisory Services Inc., First Citizens Bank & Trust Co., Cottage Street Advisors LLC, Aldebaran Financial Inc., and First Hawaiian Bank.
View insider buying and selling activity for Teladoc Health.

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TDOC stock can currently be purchased for approximately $222.23.

Teladoc Health has a market capitalization of $18.44 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,727 workers across the globe.

The official website for Teladoc Health is www.teladochealth.com.

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]